
ARPA-H will invest $100 million in quantitative measures of mental and behavioral health through Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) initiative.
Read the update from NATSAP here: ow.ly/uiRz50XxRHi
English


















